acid-phosphatase and Lung-Neoplasms

Sixteen tumor markers are reviewed, and measured to the ideal: produced by the tumor cell alone absent in health and in benign disease present in all patients with a given malignancy level in the blood representative of tumor mass detectable in occult disease. The only marker that approaches the ideal is human chorionic gonadotropin (HCG) in gestational trophoblastic tumors. In this malignancy, the HCG level suggests the diagnosis and stage, confirms response to therapy, and predicts relapse. The three most widely used and intensely studied tumor markers are carcinoembryonic antigen (CEA), alphafetoprotein (AFP), and HCG. CEA cannot be used in screening for cancer, but in carcinoma of the colon its elevation preoperatively increases the likelihood of advanced disease and postoperative recurrence. Postoperatively, elevated titers are often but not invariably associated with recurrent disease. AFP and HCG are useful in the management of nonseminomatous germ cell testicular tumors. Like CEA, they cannot be used for screening. They are more likely to be increased with advancing stage, and after therapy rising levels almost always mean recurrent disease. Some markers are valuable in specific circumstances, such as calcitonin in screening for familial medullary carcinoma of the thyroid. In multiple myeloma, immunoglobulins are useful in determining the tumor mass and response to therapy. In neuroblastoma, catecholamine metabolites are useful primarily in making the diagnosis. In some malignancies, the absence of effective therapy lowers the value of the marker, as for AFP in hepatoma. The remaining markers are too unreliable or too little studied to be useful in the management of an individual patient with cancer. The purpose of this paper is to provide the clinician with an understanding of the limitations of the present tumor markers that will lead to wiser use of the tests, and to provide standards to which future tumor markers should be measured.

Topics: Acid Phosphatase; Adrenocorticotropic Hormone; Alkaline Phosphatase; alpha-Fetoproteins; Breast Neoplasms; Calcitonin; Carcinoembryonic Antigen; Catecholamines; Chorionic Gonadotropin; Colonic Neoplasms; Female; Ferritins; Humans; Hydroxyproline; Immunoglobulins; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal; Parathyroid Hormone; Placental Lactogen; Polyamines; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vasopressins

A summary is presented of those organ specific enzyme assays traditionally used in evaluation of the patient with cancer. In addition, the use of certain serum enzymes such as gamma-glutamyl transpeptidase, phosphohexose isomerase or 5'-nucleotidase as aids in following the course of the disease, particularly in patients with metastatic spread to the liver is outlined. Also considered is the utility of enzyme analysis in biopsy tissue, biologic fluids, and washings of body cavities. Newer enzymes are considered which might, in the future, be developed as diagnostic tools or as probes for the understanding of the etiology of cancer.

Topics: Acid Phosphatase; Alkaline Phosphatase; Amylases; Aryl Hydrocarbon Hydroxylases; Bone Neoplasms; Clinical Enzyme Tests; gamma-Glutamyltransferase; Humans; Isoenzymes; Isomerases; Leucyl Aminopeptidase; Lipase; Liver Neoplasms; Lung Neoplasms; Male; Muramidase; Neoplasms; Nucleotidases; Oxidoreductases; Pancreatic Neoplasms; Prostatic Neoplasms; Sulfatases

Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Catalase; DNA Nucleotidyltransferases; Fructose-Bisphosphate Aldolase; Glycine Hydroxymethyltransferase; Hexokinase; Hodgkin Disease; Intestinal Neoplasms; Isoenzymes; L-Lactate Dehydrogenase; Leukemia; Liver; Liver Neoplasms; Lung Neoplasms; Neoplasms; Pyruvate Kinase; Ribonucleotides; Sarcoma, Experimental; Stomach Neoplasms; Uridine Kinase

Androgen deprivation displays the mean therapy of advanced stage prostatic cancer. The development of hormone-resistant disease leads to a fatal tumor progression. High-dose fosfestrol (diethylstilbestrol disphosphate) has been suggested to circumvent hormone resistance and to induce a direct cytotoxic effect. Twenty-one patients with hormone-refractory prostate cancer were enrolled in a phase I trial of continuous infusion of high, daily escalating dose of fosfestrol. Fosfestrol was given in a 3.5 hr infusion in 0.9% normal saline at a starting dose of 1.5 g/d. The dose was increased daily in the same patient according to the following schedule: 1.5, 1.8, 2.4, 3.0, 3.6, 3.9, 4.5, 5.1 and 5.7 g/d. The duration of the infusion was prolonged to 7 or 10.5 hr, if a major side effect occurred. There was neither hematological nor cardiovascular toxicity. The main dose-limiting toxicities were nausea/vomiting in 17 patients, edema in 2 patients, and more than 5% weight gain in 3 patients. The planned maximal dose was reached in 10 patients during a 3.5 hr infusion, and in 3 additional patients, after infusion prolongation. Seven patients experienced a subjective improvement: Prostatic acid phosphatase and prostatic specific antigen decreased in 4 out of 11 and in 7 out of 12 patients, respectively. The suggested dose to phase II trial is 4 g/d in 3.5 hr infusion for a duration of up to 10 days.

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Drug Resistance; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms

Bone metastases develop in several malignancies (multiple myeloma, breast, prostate and lung carcinoma) and cause several complications. The aim of this study was to search for new biomarkers to use in monitoring of bone metastatic disease with the use of xMAP technology.. We assessed 62 oncological patients: 23 with no bone metastases, 28 with metastatic disease not having undergone therapy and 11 with metastatic disease treated by denosumab. Serum levels of dickkopf-related protein 1 (DKK1), growth differentiation factor-15 (GDF15), neuron-specific enolase (NSE), osteoprotegerin (OPG), osteonectin, periostin, tartrate-resistant acid phosphatase (TRAP5), tumor necrosis factor related weak inducer of apoptosis (TWEAK), chitinase-3-like protein 1 (YKL40), carboxy-terminal telopeptide (CTX) and procollagen type 1 N-terminal propeptide (PINP) were measured in each sample.. The following biomarkers were observed to have significantly higher levels in the groups of patients with metastases in comparison to metastasis-free patients: GDF15 (p<0.0001), osteonectin (p=0.0311), TRAP5 (p<0.0046), TWEAK (p<0.0343) and YKL40 (p<0.0034). The changes in DKK1, NSE, OPG and periostin were not significant.. We identified five new biomarkers: GDF15, osteonectin, TRAP5, TWEAK, and YKL40 as being promising markers for monitoring bone metastases.

Topics: Acid Phosphatase; Adipokines; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Chitinase-3-Like Protein 1; Colorectal Neoplasms; Cytokine TWEAK; Female; Growth Differentiation Factor 15; Humans; Isoenzymes; Lectins; Lung Neoplasms; Male; Middle Aged; Osteonectin; Pilot Projects; Prostatic Neoplasms; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factors

The addition of phosphate groups is an essential requirement for the proper functioning of cyclin and cyclin dependent kinase which control various stages in the mitotic division of cancer cells. Thus limiting the availability of phosphate is likely to interfere with the metabolism of rapidly growing malignant cells. The human hormone glucagon and the anti metabolite mithramycin reduce serum phosphate by increasing phosphaturia and are both very effective in treating Paget's disease of bone, a precancerous condition. In this disorder large doses of glucagon given intravenously relieve bone pain and cause serum phosphate and alkaline phosphatase as well as urine hydroxyproline to fall, indicating a marked reduction in bone turnover. A constant iv infusion of glucagon was given to each of three patients all of whom had secondary malignant bone deposits. Two of the patients had primary prostate cancer and one had a squamous cell lung tumour. All three patients had relief of bone pain and a fall in serum alkaline phosphatase. Serum acid phosphatase also fell in the two patients with prostate cancer. It is proposed that the marked drop in serum phosphate due to glucagon causes intracellular phosphate to fall. This in turn disrupts the addition and removal of phosphate groups essential for the proper functioning of cyclin and cyclin dependent kinase. These two proteins control the transition from G1 to S (DNA synthesis phase) and G2 to M (mitotic phase) in the dividing cycle of malignant cells. Depriving a tumour of an essential ingredient used in phosphorylation reactions will disrupt its growth. It is also proposed that, by the same mechanism, glucagon induced hypophosphataemia renders malignant cells more sensitive to established chemotherapeutic agents and radiation waves. If this hypothesis proves to be correct, lowering intracellular phosphate may become an useful tool in cancer therapy. However extensive studies are necessary to determine whether mitosis in cancer cells can be advantageously disrupted by glucagon induced hypophosphataemia.

Topics: Acid Phosphatase; Alkaline Phosphatase; Bone and Bones; Carcinoma, Squamous Cell; Glucagon; Humans; Hydroxyproline; Hypophosphatemia, Familial; Insulin; Lung Neoplasms; Male; Mitosis; Models, Theoretical; Neoplasms; Osteitis Deformans; Phosphates; Phosphorylation; Prostatic Neoplasms

This study determined the effects of a high-fat diet and plasminogen activator inhibitor-1 deficiency (Pai1(-/-)) on the bone structure in male C57BL/6 mice bearing Lewis lung carcinoma (LLC) in lungs. Significant reduction in bone volume fraction (BV/TV), trabecular number (Tb.N) and bone mineral density (BMD) in femurs and vertebrae were found in LLC-bearing mice compared to non-tumor-bearing mice. In LLC-bearing mice, the high-fat diet compared to the AIN93G control diet significantly reduced BV/TV, Tb.N and BMD in femurs and BV/TV in vertebrae. The high-fat diet significantly reduced BMD in vertebrae in wild-type mice but not in Pai1(-/-) mice. Compared to wild-type mice, PAI1 deficiency significantly increased BV/TV and Tb.N in femurs. The plasma concentration of osteocalcin was significantly lower and that of tartrate-resistant acid phosphatase 5b (TRAP5b) was significantly higher in LLC-bearing mice. The high-fat diet significantly reduced plasma osteocalcin and increased TRAP5b. Deficiency in PAI1 prevented the high-fat diet-induced increases in plasma TRAP5b. These findings demonstrate that a high-fat diet enhances, whereas PAI1 deficiency, attenuates metastasis-associated bone loss, indicating that a high-fat diet and PAI1 contribute to metastasis-associated bone deterioration.

Topics: Acid Phosphatase; Animals; Bone and Bones; Bone Density; Carcinoma, Lewis Lung; Diet, High-Fat; Hemorrhagic Disorders; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Osteocalcin; Plasminogen Activator Inhibitor 1; Tartrate-Resistant Acid Phosphatase

We investigated the clinical significance of serum bone-specific alkaline phosphatase (BAP), tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) and type I collagen carboxyterminal telopeptide (ICTP) as bone metabolic markers for bone metastasis (BM) screening in lung cancer patients.. Newly diagnosed advanced lung cancer patients with (N = 130) and without (N = 135) BM were enrolled in the study. Serum BAP, TRACP 5b and ICTP were measured before the treatment.. BAP, TRACP 5b and ICTP values were higher in patients with BM compared with patients without BM (all P < 0.0001). Area under ROC curve (AUC) of BAP, TRACP 5b and ICTP was 0.760, 0.753 and 0.835 (all P < 0.0001), respectively. The cut-off values for BAP, TRACP 5b and ICTP were 21.8 μg/l, 7.8 U/l and 8.8 μg/l, respectively. When TRACP 5b and ICTP were combined, AUC was elevated to 0.895 (P < 0.0001), and the cut-off values were TRACP 5b 7.6 U/l and ICTP 8.4 μg/l.. We conclude that serum BAP, TRACP 5b and ICTP may serve as useful tools for BM screening in lung cancer patients.

Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Collagen Type I; Female; Humans; Isoenzymes; Lung Neoplasms; Male; Middle Aged; Peptides; Tartrate-Resistant Acid Phosphatase; Young Adult

Diagnosis and follow-up of bone metastasis (BMet) in non-small cell lung cancer (NSCLC) patients usually rely on symptoms and image studies. A serum marker of bone resorption may improve the quality of treatment in such patients. Tartrate-resistant acid phosphatase 5b (TRACP5b) is a specific marker for osteoclasts and we proposed it can be used as a marker of BMet in NSCLC patients.. In November 2002 till August 2008 serum samples were obtained from 141 newly diagnosed stage IIIA, IIIB or IV NSCLC patients and 41 normal subjects. All patients received baseline bone scintinography examination and evaluation of clinical symptoms as a standard of BMet diagnosis. Patients were divided into 2 groups by having BMet (Group I, n = 72) or not (Group II, n = 69). An in-house immunoassay using a TRACP-specific monoclonal antibody, 14G6, was used to measure the serum TRACP5b activity at pH 6.1.. The mean serum TRACP5b activities of Group I, Group II and normal subjects were 3.50 ± 2.2 3U/l, 2.09 ± 0.72 U/l and 2.33 ± 0.52 U/l, respectively. After adjusting for age, stage, gender, and histology in a generalized linear model, Group I has significantly higher TRACP5b activity than Group II (p < 0.001). The receiver operating characteristic analysis established a cutoff value of 2.551 U/l to identify BMet in NSCLC patients with a sensitivity of 63.9% and a specificity of 76.8%. TRACP5b activity declined in patients who responded to treatment (p = 0.047), and elevated in patients who developed new BMet (p = 0.05).. Serum TRACP5b activity test is a potentially useful adjunct in diagnosing and monitoring BMet in NSCLC. Further study is warranted to establish its real value in diagnosis and monitoring of BMet in NSCLC patients.

Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Follow-Up Studies; Humans; Isoenzymes; Lung Neoplasms; Male; Middle Aged; ROC Curve; Tartrate-Resistant Acid Phosphatase

Osteosarcoma (OS) is the most common primary malignant bone tumour, and mainly affects adolescents and young adults. Although there has been substantial improvement in management of OS with surgery and chemotherapy, further survival increase has not been achieved over the past two decades.. We focused on the receptor activator of nuclear factor kappaB ligand (RANKL)-osteoclast (OCL) system as a biological target for OS. RANKL is a critical factor for OCL formation and bone resorption activity. The primary lesion in bone and ensuing metastasis in OS both require the induction of OCLs. RANK-Fc is a potent RANKL antagonist and inhibitor of OCL formation and activity.. In an orthotopic model in Balb/c nu/nu mice, a twice weekly dosing regimen of 350 microg of RANK-Fc per mouse subcutaneously (n= 5) reduced lung metastasis (P > 0.05), preserved bone structure and reduced tartrate-resistant acid phosphatase (TRAP)(+) OCLs (P < 0.005) in OS-bearing bone. In vitro, RANK-Fc suppressed OCL formation (P < 0.005), bone resorption activity (P < 0.005) and RANKL-induced anti-apoptosis (P < 0.5) of OCLs.

Topics: Acid Phosphatase; Animals; Apoptosis; Bone and Bones; Bone Neoplasms; Bone Resorption; Disease Models, Animal; Humans; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Osteoclasts; Osteosarcoma; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Fusion Proteins; Tartrate-Resistant Acid Phosphatase

We conducted a transcriptomic screen of osteosarcoma (OS) biopsies and found that expression of osteoclast-specific tartrate-resistant acid phosphatase 5 (ACP5/TRAP) is significantly downregulated in OS compared with nonmalignant bone (P < 0.0001). Moreover, lesions from OS patients with pulmonary metastases had 2-fold less ACP5/TRAP expression (P < 0.018) than lesions from patients without metastases. In addition, we found a direct correlation (P = 0.0166) between ACP5/TRAP expression and time to metastasis. Therefore, we examined whether metastasis-competent (MC) OS cells could induce loss of ACP5(+) osteoclasts and contribute to metastasis. We found that MC OS cell lines can inhibit osteoclastogenesis in vitro and in vivo. In addition, osteoclasts can inhibit the migration of MC OS cells in vitro. Finally, ablation of osteoclasts with zoledronic acid increases the number of metastatic lung lesions in an orthotopic OS model, whereas fulvestrant treatment increases osteoclast numbers and reduces metastatic lesions. These data indicate that the metastatic potential of OS is determined early in tumor development and that loss of osteoclasts in the primary lesion enhances OS metastasis.

Topics: Acid Phosphatase; Adolescent; Adult; Aged; Animals; Biopsy; Bone Neoplasms; Child; Female; Humans; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Osteoclasts; Osteosarcoma; Tartrate-Resistant Acid Phosphatase; Young Adult

In this study we produced a recombinant human Tartrate-resistant acid phosphatase (TRAP) enzyme from baculovirus-infected insect cells, generated four monoclonal antibodies (MAbs) 15A4, 13B9, 1C6 and 3G7, to the enzyme, and characterized these antibodies. In the human serum and lung specimen, all four antibodies appeared to have a high specificity for native TRAP enzyme in western blot analysis, immunohistochemical analysis and enzyme immunoassay. These antibodies may react with respective conformational determinants, therefore, they may be useful for detection of active TRAP. Only one of the antibodies, 15A4 also reacted with a denatured epitope, therefore, it is suitable for western blot analysis, enzyme immunoassay and for immunohistochemistry in the rat. Taken together, having characterized properties of four monoclonal antibodies against recombinant human TRAP enzyme may be useful for development of TRAP specific immunoassays in pathology and hematology of the bone. They will certainly be of use for the study of biosynthesis, regulation and function of the TRAP enzyme.

Topics: Acid Phosphatase; Animals; Antibodies, Monoclonal; Bone and Bones; Humans; Immunoassay; Isoenzymes; Lung Neoplasms; Macrophages; Organ Specificity; Rats; Recombinant Proteins; Tartrate-Resistant Acid Phosphatase

We undertook a detailed histologic study to identify specific morphologic features that may aid in distinguishing prostatic adenocarcinoma with lung metastases (PALM) from other pulmonary tumors with similar histologic features. In 16 cases, we found 3 predominant architectural patterns: microacinar (n = 10), tubulopapillary (ductal; n = 4), and carcinoid-like (n = 2). Characteristic features of PALM included small acinar and/or cribriform growth, frequent lymphangitic permeation, lack of stromal response, uniform round nuclei with prominent nucleoli, intraluminal blue mucin, and prominent cell borders. By immunohistochemical staining, prostate-specific antigen and prostate-specific acid phosphatase were present in 13 of 14 and 13 of 13 cases, respectively. Metastatic prostatic duct adenocarcinoma exhibited morphologic features similar to metastatic colonic adenocarcinoma. Two cases had a carcinoid-like appearance with nested or solid architecture, parachromatin clearing, and prominent nucleoli, but lacked the finely stippled chromatin pattern of carcinoid tumors. Several features that may result in misinterpretation or lack of association of the neoplasm in the lung with a prostatic primary include lung metastasis preceding the detection of a prostatic primary tumor, solitary pulmonary nodule, tubulopapillary (ductal) or carcinoid-like pattern, scant material in which histologic features of metastatic prostate carcinoma are not fully appreciated, and frequent necrosis. Attention to specific discriminating histologic features, supported by immunohistochemical staining, may be useful in the differential diagnosis, which is therapeutically and prognostically critical.

Topics: Acid Phosphatase; Adenocarcinoma; Cell Nucleolus; Cell Nucleus; Diagnosis, Differential; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mucins; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms

The aim of the study was an assessment of some lysosomal enzymes activity in serum and in tumors of patients with lung cancer histopathologically confirmed as squamous cell lung carcinoma. The first group constisted of 10 patients with stage II of the disease and the second group consisted of 11 patients with stage III of the disease. Lysosomal enzymes activities were assayed in serum before surgery and on the 10th day after surgery in serum and in tumors. Arylsuphatase, cathepsin D and acid phosphatase activities were higher in the patients serum than in that of the control group. The decrease of arylsulphatase and cathepsin D activities after surgery was statistically significant in both groups of patients, but the cathepsin D activity was still 3 times higher in patients than in those from the control group. The decrease of acid phosphatase activity after surgery was about 50% in both groups of patients and this decrease was statistically significant. The arylsulphatase and acid phosphatase activity in tumors was nearly 3 times higher in stage III patients than it was in stage II patients, but the cathepsin D activity was nearly the same in both patient groups. Higher lysosomal enzyme activity may be a useful factor in diagnosing and monitoring of lung cancer. However, further investigations are needed.

Topics: Acid Phosphatase; Adult; Arylsulfatases; Carcinoma, Squamous Cell; Case-Control Studies; Cathepsin D; Humans; Hydrolases; Lung Neoplasms; Lysosomes; Middle Aged; Neoplasm Staging

An autopsy case of cardiac leiomyosarcoma and its pulmonary metastasis, both with osteoclast-like multinucleated giant cells (OMGC) mimicking the so-called giant cell variant of malignant fibrous histiocytoma (MFH), is reported. The patient, a 70-year-old male, was admitted for sudden dyspnea. Extensive work-up established only a left atrial tumor mass. Three months after admission, the patient developed multiple intracranial and pulmonary metastases, followed by a worsening clinical course characterized by semicoma and dyspnea, and subsequently died 6 months after the onset of his symptoms. At subsequent autopsy, the left atrial polypoid tumor was found to have invaded destructively to the left half of the cardiac wall. Histology of the cardiac tumor revealed a bimorphic sarcoma in which a poorly differentiated leiomyosarcoma comfirmed by histologic and immunohistochemical findings was juxtaposed to a small nodule with features closely mimicking giant cell MFH. The pulmonary metastatic nodules exhibited features that were entirely indistinguishable from giant cell MFH except for the fact that a minority of polymorphic cells manifested myogenic differentiation. We believe that such a MFH-like pattern represents a pleomorphic form of leiomyosarcoma rather than a dedifferentiated one. The OMGC within the MFH-like component coexpressed CD68 and tartrate-resistant acid phosphatase activity.

Topics: Acid Phosphatase; Actins; Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Fatal Outcome; Giant Cells; Heart Neoplasms; Humans; Immunohistochemistry; Isoenzymes; Leiomyosarcoma; Lung Neoplasms; Male; Osteoclasts; Tartrate-Resistant Acid Phosphatase

The antitumor effect of intra-tumoral injection of Cepharanthin, a biscoclaurin alkaloid extracted from Stephania cephalanta Hayata, and staphylococcal enterotoxin B was evaluated using F344 male rats bearing transplantable rat osteosarcoma, S-SLM. A macroscopic lung metastatic nodule of tumor was transplanted into the subcutaneous back space, and 0.5 mg of Cepharanthin and 2 pg of staphylococcal enterotoxin B were injected into the tumor on days 12, 13 and 14. On day 28, all animals were killed with an overdose of pentobarbital sodium, and the transplanted tumors and lungs were examined. The wet weight of the lungs of the rats treated with Cepharanthin and staphylococcal enterotoxin B was significantly lower, and apoptosis in the lung metastatic nodules was significantly higher than that of the control or that of rats treated with only Cepharanthin or staphylococcal enterotoxin B. In the transplanted tumors, infiltration of TRAP (tartrate-resistant acid phosphatase)-positive multinucleated giant cells was prominent in the rats treated with Cepharanthin and staphylococcal enterotoxin B. These findings indicate that intra-tumoral injection of Cepharanthin and staphylococcal enterotoxin B induced infiltration of TRAP-positive multinucleated giant cells within the transplanted rat osteosarcoma, and reduced lung metastasis.

Topics: Acid Phosphatase; Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Enterotoxins; In Situ Nick-End Labeling; Isoenzymes; Lung Neoplasms; Male; Neoplasm Transplantation; Organ Size; Osteosarcoma; Rats; Rats, Inbred F344; Tartrate-Resistant Acid Phosphatase

A case is presented of a middle-aged man suffering from stage D2 prostate cancer with pulmonary metastases who responded favorably, first, to endocrine combination therapy with the antiandrogen flutamide and an LHRH agonist for 5.5 years, and, second, to the subsequent withdrawal of Flutamide at the time of the progression of the disease. This case has several exceptional features: absence of bone metastases, pulmonary metastatic nodules characterized as focal neuroendocrine differentiation, and a positive response to antiandrogen withdrawal upon relapse of metastases after initial positive response. The concept of escape to androgen blockade and development of androgenic hypersensitivity is discussed.

Topics: Acid Phosphatase; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone and Bones; Flutamide; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Sputum; Tomography, X-Ray Computed; Triptorelin Pamoate

Metastatic pulmonary adenocarcinoma was found in a 79-year-old man, who had symptoms of general malaise and poor appetite. An extensive work-up including a transurethral resection of the prostate, failed to establish the primary site of the malignancy. By administering chlormadinone acetate for prostatic hypertrophy, the pulmonary metastases improved dramatically. The tumor cells in the lung, which had previously been obtained by transbronchial lung biopsy, stained positive for prostatic acid phosphatase and prostatic specific antigen. These data suggested that prostatic carcinoma had metastasized to the lung. The prostatic carcinoma was finally confirmed at autopsy.

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Biomarkers, Tumor; Humans; Immunohistochemistry; Lung; Lung Neoplasms; Male; Prostate-Specific Antigen; Prostatic Neoplasms

We report a case of advanced prostate cancer in which an initial response to hormonal therapy with surgical castration and estramustine phosphate (EMP) was followed by disease progression, as shown by sequential elevations in serum prostate specific antigen (PSA) and prostate acid phosphatase (PAP) and the development of new symptoms, during maintenance endocrine and anti-cancer chemotherapy. Discontinuation of EMP resulted in sustained reductions in serum PSA and PAP levels and a sustained improvement in symptoms.

Topics: Acid Phosphatase; Adenocarcinoma; Biomarkers, Tumor; Bone Neoplasms; Castration; Estramustine; Humans; Lung Neoplasms; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms

In order to study the mechanism of the effects of M phi on tumor cells, enzyme cytochemistry and morphometry were used to investigate the activities of cytochrome oxidase (CO), succinate dehydrogenase (SD), lactate dehydrogenase (LDH) and acid phosphatase (ACP) in A549 pulmonary alveolar cell carcinoma cells which had been interacted with normal and CP-activated macrophages respectively. It was found that when E/T = 10:1, the enzyme activity of the cancer cell mitochondria, CO, SD, LDH were decreased, and when E/T = 20:1, the activity of the lysosomal enzyme ACP was increased. These results indicate that when the E/T ratio was appropriate, activated M phi may injure the mitochondria and lysosomes and affect the aerobic respiration and oxidative phosphorylation of cancer cells. This may be one of the cytostatic and cytotoxic mechanisms of activated M phi on tumor cells.

Topics: Acid Phosphatase; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Lung Neoplasms; Lysosomes; Macrophages, Peritoneal; Male; Mice; Mitochondria; Oxidoreductases; Tumor Cells, Cultured

The immunohistochemical demonstration of prostatic acid phosphatase (PAcP) and/or prostate-specific antigen (PSA) has been accepted as being reliable in identifying metastatic adenocarcinoma of prostate origin. However, islet cell tumors, especially hindgut-derived carcinoid tumors, have occasionally been reported to be positive for PAcP. We therefore studied a series of carcinoid tumors of the lung and gastrointestinal tract immunohistochemically for PAcP expression by using two polyclonal antibodies and one monoclonal antibody. Thirty-three carcinoid tumors were examined. All five rectal carcinoids in the series showed convincing PAcP positivity with at least two of the three anti-PAcP antibodies. No significant PAcP positivity was observed in the remaining 28 foregut- and midgut-derived carcinoid tumors, except for weak focal positivity in one lung carcinoid. PSA antibody reacted negatively in all cases. Western blots of an aqueous cell lysate from one rectal carcinoid revealed protein bands in the region of 45-55 kd that immunoreacted with anti-PAcP antibodies, confirming the validity of the immunostains. These results suggest that PAcP positivity is common in rectal carcinoid tumors and that it most likely represents true PAcP expression. This seemingly aberrant protein expression may be explained by the shared cloacal derivation of the rectum and prostate, giving rise to cells with both endocrine and partial prostatic epithelial differentiation.

Topics: Acid Phosphatase; Adenocarcinoma; Antigens, Neoplasm; Blotting, Western; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Immunohistochemistry; Lung Neoplasms; Male; Prostate-Specific Antigen; Rectal Neoplasms; Retrospective Studies

The natural killer activity (NKA) of human mononuclear cells and the activity of the lysosomal enzymes of these cells (arylsulfatase, acid phosphatase and beta-glucuronidase) has been studied in norm and under human lung cancer. The mononuclear cells were isolated from peripheral blood of 10 healthy donors and 20 patients with lung cancer of II-III stages. Under the action of mononuclear cells on the target cells (human erythroleukosis cells K-562 labeled with 3H-uridine) the NKA of mononuclear cells of patients was seen to decrease (cytotoxic index = 54.8 +/- 6.4%), in comparison with that of healthy donors (cytotoxic index = 65.1 +/- 4.5%). Simultaneously a decrease in arylsulfatase activity (0.05 +/- 0.01 nmoles/10(6) cells/min) was found in comparison with the control value (0.11 +/- 0.01 nmoles/10(6) cells/min). In 2-3 weeks after the operation the NKA value (cytotoxic index = 50.2 +/- 5.8%) was restored and arylsulfatase activity (0.09 +/- 0.02 nmoles/10(6) cells/min) was increased. There was no correlation between the NKA value and the activities of acid phosphatase and beta-glucuronidase. The parallelism observed between changes in NKA value and arylsulfatase activity may suggest a possible participation of this enzyme in the killing mechanism at the stage of cerebroside sulfate ester degradation of the target cell membrane to initiate the lytic events.

Topics: Acid Phosphatase; Aged; Arylsulfatases; Cell Separation; Cytotoxicity Tests, Immunologic; Glucuronidase; Humans; Killer Cells, Natural; Lung Neoplasms; Lysosomes; Middle Aged; Pneumonectomy; Postoperative Period

A novel amylase gene (amy3) that differs in nucleotide sequence from salivary amylase gene (amy1) and pancreatic amylase gene (amy2) has been described [Tomita et al., Gene 76 (1989) 11-18], but whether this gene can ever code for an active enzyme has not been shown. We prepared cDNA of this gene from an mRNA obtained from lung carcinoid tissue, and expressed it in Saccharomyces cerevisiae under the control of an acid phosphatase promoter. The product was secreted into culture media, and showed enzymatic activity, demonstrating that this novel alpha-amylase gene (amy3) can code for a functional isozyme. We purified this enzyme, and compared its biological properties with those of salivary and pancreatic human amylases similarly expressed in yeast. We observed that the novel amylase isozyme is more heat-sensitive than others, and that its substrate specificity is different from the other two isozymes.

Topics: Acid Phosphatase; alpha-Amylases; Amino Acid Sequence; Carbohydrate Conformation; Carbohydrate Sequence; Cloning, Molecular; Gene Expression; Humans; Isoenzymes; Kinetics; Lung Neoplasms; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Restriction Mapping; Saccharomyces cerevisiae; Sequence Homology, Nucleic Acid; Substrate Specificity

Topics: Acid Phosphatase; Acquired Immunodeficiency Syndrome; Humans; Lung Neoplasms; Macrophages; Phagocytosis; Pulmonary Alveoli; Sarcoidosis; Staphylococcus aureus

A murine monoclonal antibody PASE/4LJ to prostatic acid phosphatase (PAP) was used to immunostain a wide variety of sections of benign and malignant tissues (654 blocks). Non-neoplastic adult and fetal prostatic glands, primary and metastatic prostatic carcinomas, and scattered cells in prostatic and penile urethra were positive. Rat, dog and rabbit prostates were negative. Nine of 400 tumours of non-prostatic origin showed some positivity: 6/36 carcinoids, 1/9 islet cell tumours, 1/55 ovarian adenocarcinomas (serous) and one carcinosarcoma of the lung (epithelial portion). Positive staining was seen in islet cells in 4/5 specimens of normal pancreas, and in 4/9 blocks of normal pancreas surrounding a pancreatic tumour. Loops of Henle, maculae densae, and distal tubules in 10/10 fetal and 2/9 adult kidneys were also positive, with proximal tubules and collecting ducts negative. All other 159 blocks of non-neoplastic adult and fetal tissues were negative. The antibody was also affinity purified from ascitic fluid, and shown not to inhibit the enzyme activity of prostatic acid phosphatase.

Topics: Acid Phosphatase; Adult; Animals; Antibodies, Monoclonal; Dogs; Female; Humans; Immunohistochemistry; Kidney; Lung Neoplasms; Male; Ovarian Neoplasms; Prostate; Prostatic Neoplasms; Rabbits; Rats

1. The interactions of B16-F1 and B16-F10 tumors with their surrounding tissues in terms of enzyme activities such as cathepsin B, hemoglobin(Hb)-hydrolase, acid phosphatase, beta-glucuronidase and plasminogen activator were investigated when said tumors proliferated locally and at secondary sites throughout the host's circulatory system. 2. In the case of B16-F1 and B16-F10 tumor cells proliferating under the skin, statistical differences were not detected between the enzyme activities of the skin surrounding the tumors and control skin, nor between B16-F1 and B16-F10 tumors, except for beta-glucuronidase. 3. In the case of B16-F1 and B16-F10 tumor cells metastasizing to lung, statistical differences were detected between numerous enzyme activities of the lung tissues surrounding the tumors and control lung tissue, and also between B16-F1 and B16-F10 tumors. 4. The activities of cathepsin B and acid phosphatase of lung tissue surrounding B16-F1 tumor were lower than those of the control lung. 5. beta-Glucuronidase activity of lung tissue surrounding B16-F10 tumor was higher than that of the control lung. 6. The activities of cathepsin B, Hb-hydrolase and beta-glucuronidase of the B16-F10 tumor were higher than those of the B16-F1 tumor. 7. Results indicate that metastasized B16 melanoma tumor cells interact with surrounding lung tissues, and that cathepsin B, Hb-hydrolase and beta-glucuronidase might play important roles in the metastasis of the malignant tumor.

Topics: Acid Phosphatase; Animals; Cathepsin B; DNA, Neoplasm; Glucuronidase; Lung Neoplasms; Melanoma, Experimental; Mice; Peptide Hydrolases; Plasminogen Activators; Skin Neoplasms

Recognition of disseminated adenocarcinomas potentially responsive to current treatment programs is an important objective in the management of cancer patients. Metastatic adenocarcinoma of the prostate gland is a malignant entity which often can be palliated effectively by hormonally based therapeutic strategies. In cases of metastatic prostate cancer presenting with typical clinical features, the correct diagnosis can be readily achieved, but in patients with less obvious presentations the diagnosis of prostatic carcinoma may be overlooked. In the current report, a group of elderly men presenting with a clinical syndrome resembling either metastatic primary adenocarcinoma of the lung or primary adenocarcinoma of the lung coexisting with prostate cancer were found in fact to have metastatic prostatic carcinoma as their sole disease process. In each case, cytologic characterization of clinically involved tissue specimens by the prostate specific antigen and prostatic acid phosphatase immunohistochemical markers enabled clinical investigators to arrive at the correct diagnosis. Other clinical features, such as a positive bone scan and an enlarged prostate gland on physical exam and/or radiographic studies were noted to be present in these patients. All the patients in the current series responded to hormonal treatment regimens once the diagnosis of metastatic prostate cancer had been established. In elderly male patients presenting with what appears to be primary adenocarcinoma of the lung, the diagnosis of metastatic prostate cancer should be considered and when necessary evaluated by the use of appropriate clinical and immunohistochemical studies.

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Male; Neoplasms, Unknown Primary; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms

Topics: Acid Phosphatase; Chronic Disease; Evaluation Studies as Topic; Humans; Leukocyte Count; Lung Neoplasms; Lymphocyte Activation; Phytohemagglutinins; Pneumonia

Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers, Tumor; Cell Differentiation; Esterases; Humans; Lung Neoplasms

Metastases of 47 known prostatic carcinomas were subjected to the unlabeled immunoperoxidase procedure to localize prostate acid phosphatase (PAP) and prostate-specific antigen (PSA). PAP was found in 64% and PSA in 78% of bone marrow, lymph node, lung and liver metastases investigated. There was no significant difference between the intensity of staining in primary and metastatic neoplasms. Staining of PAP and PSA was found to be less intense in poorly differentiated metastases of prostatic adenocarcinomas. The data suggest that the demonstration of PAP and PSA is a practical and sensitive test for determining the prostatic origin of a clinically and histologically unclassifiable metastasis.

Topics: Acid Phosphatase; Antigens, Neoplasm; Bone Marrow; Humans; Immunoenzyme Techniques; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms

In 33 patients with lung cancer (6 women and 27 men, aged at average 61.2 years) the activity and intracellular localization of acid phosphatase, beta-glucuronidase and N-acetyl-beta-glucosaminidase in peripheral blood lymphocytes were determined by means of semiquantitative cytochemical methods. In comparison to the control group of healthy subjects, the patients with lung cancer showed increased counts of acid phosphatase-positive lymphocytes with granular-diffuse cytochemical reaction, increased counts of beta-glucuronidase-positive lymphocytes with solely granular type of reaction and increased numbers of N-acetyl-beta-glucosaminidase-positive cells showing the granular, granular-diffuse and diffuse type of reaction. The total count of beta-glucuronidase-positive and N-acetyl-beta-glucosaminidase-positive lymphocytes was significantly elevated in these patients. The authors discuss the significance of their observations for evaluating lymphocyte response in patients with lung cancer.

Topics: Acetylglucosaminidase; Acid Phosphatase; Adenocarcinoma; Aged; Carcinoma; Carcinoma, Squamous Cell; Female; Glucuronidase; Hexosaminidases; Humans; Lung Neoplasms; Lymphocytes; Male; Middle Aged

Human alveolar macrophages (AM) were obtained by bronchoalveolar lavage from 18 patients with a variety of conditions. For each patient the percentages of AM showing the following properties were determined: (1) staining for the enzymes non-specific esterase (NSE) and acid phosphatase (ACP); (2) in vitro phagocytosis of Candida guillermondii; (3) expression of cell surface markers detected by two monoclonal antibodies (MoAb) (1B5 and DA2) and two anti-monocyte/macrophage MoAb (UCHMI and RFD2); and (4) simultaneous phagocytosis of C. guillermondii and staining with the MoAb. In all patients the majority of AM were found to be Ia positive (90 +/- 10%) ACP positive (100%) and NSE positive (97 +/- 4%). In contrast a smaller proportion were UCHM1 and RFD2 positive (77 +/- 11%, 68 +/- 12%) and less were phagocytic (37 +/- 17%). Whilst the total percentage of cells staining with the MoAb was unaltered by phagocytosis, the proportion of UCHM1 or RFD2 positive cells was significantly higher in the phagocytic population than in the non-phagocytic population (90% and 85%, as opposed to 65% and 55%, P less than 0.001). Thus only a proportion of Ia positive AM expressed monocyte/macrophage antigens and were phagocytic. Such heterogeneity may reflect different stages of macrophage maturation or the existence of macrophage subpopulations with functionally distinct roles in airways immunity.

Topics: Acid Phosphatase; Antibodies, Monoclonal; Antigens, Surface; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Count; Histocompatibility Antigens Class II; Humans; Lung Diseases; Lung Neoplasms; Macrophages; Phagocytosis; Pulmonary Alveoli; Sarcoidosis

Metastases of 47 known prostatic carcinomas were subjected to the unlabelled immunoperoxidase-procedure to localise prostaticacid-phosphatase (PAP) and prostatic-specific antigen (PSA). In bone-marrow, lymph-node, lung and liver metastases PAP was found in 64% and PSA in 78%. There was no significant difference between the intensity of staining in primary and metastatic neoplasm. In poorly differentiated metastases of prostatic adenocarcinomas less intense staining for PAP and PSA was found. The data suggest that the demonstration of PAP and PSA is a practical and sensitive test for the prostatic origin of a clinically and histologically unclassifiable metastasis.

Topics: Acid Phosphatase; Antigens, Neoplasm; Carcinoma; Humans; Immunoenzyme Techniques; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms

Conventional antibodies against prostatic acid phosphatase, labeled with iodine-131, have been administered to patients with prostatic carcinoma for the external scintigraphic imaging of tumors containing prostatic acid phosphatase (radioimmunodetection). The method has been found to be safe and reliable for imaging of primary tumors and non-bone metastases, even differentiating between lung tumors of prostatic and pulmonary origin.

Topics: Acid Phosphatase; Animals; Antibodies; Bone Neoplasms; Carcinoma; Goats; Humans; Iodine Radioisotopes; Isotope Labeling; Lung Neoplasms; Male; Prostate; Prostatic Neoplasms; Rabbits; Radionuclide Imaging; Serum Albumin; Sodium Pertechnetate Tc 99m; Technetium; Technetium Tc 99m Aggregated Albumin

Topics: Acid Phosphatase; Adult; Enzyme Activation; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Molecular Weight; Subcellular Fractions

Radioimmunodetection (RAID) of prostatic cancer is done by injecting 131I-labeled rabbit antibody IgG against prostatic acid phosphatase (PAP) and performing total-body photoscans with a gamma scintillation camera. Of two patients tested, the PAP RAID scintiscans located the primary or recurrent prostatic cancers in both and showed no disease in the lungs of the patient shown subsequently to have lung cancer. The lung tumor nodules showing anti-PAP IgG accretion were assumed to be of prostatic cancer origin, since one of the original tumors removed from this patient's other lung a year earlier stained for PAP by immunohistochemistry. This study showed that PAP RAID can locate primary and metastatic tumors of prostatic origin.

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Animals; Antigens, Neoplasm; Clinical Enzyme Tests; Humans; Immunoenzyme Techniques; Immunoglobulin G; Iodine Radioisotopes; Lung; Lung Neoplasms; Male; Prostate; Prostatic Neoplasms; Rabbits; Radionuclide Imaging

Quantitative morphometric analyses of macrophages should facilitate a more precise definition of the role of macrophages in neoplastic diseases and inflammatory diseases of lymphoid and hemopoietic tissues. The usefulness of the available phenotypic markers is affected by the extent to which they are expressed by macrophages in tissue sections. For our study of phenotypic markers for macrophages in human tissue sections, we selected lung, since pulmonary alveolar macrophages are more readily identified morphologically in tissue sections than macrophages in most other tissues. In 1-2 micron sections of freshly fixed lung embedded in methacrylate, 89.7% of pulmonary alveolar macrophages had histochemically demonstrable acid phosphatase; 86.2%, nonspecific esterase with naphthol ASD chloroacetate as the substrate; 86.2%, nonspecific esterase with alpha-naphthyl butyrate as the substrate; 80.5%, peroxidase; and 75.8%, iron. With respect to their expression of markers, the observed heterogeneity among pulmonary alveolar macrophages is interesting; this heterogeneity may reflect the degree to which they have been activated, the different periods of time since they arrived in the lung, and differences in their local environments. Except for peroxidase, all examined markers were as well demonstrated when tissues were fixed after storage over liquid nitrogen as when fixation was carried out with fresh tissue. Acid phosphatase and nonspecific esterase with the chloroactetate substrate gave bright colors that would facilitate morphometric analyses. The storage of tissue over liquid nitrogen will be equally satisfactory for the characterization of macrophages with histochemical markers and monoclonal antibodies.

Topics: Acid Phosphatase; Carcinoma, Bronchogenic; Enzymes; Esterases; Frozen Sections; Histocytochemistry; Humans; Iron; Lung Neoplasms; Macrophages; Peroxidases; Pulmonary Alveoli; Tissue Preservation

Topics: Acid Phosphatase; Adolescent; Adult; Aged; Carboxylesterase; Carboxylic Ester Hydrolases; Female; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Microscopy, Electron; Middle Aged

Topics: Acid Phosphatase; Adenocarcinoma; Animals; Cytotoxicity, Immunologic; Exocytosis; Female; Guinea Pigs; Liposomes; Liver Neoplasms, Experimental; Lung Neoplasms; Lysosomes; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred DBA; Neoplasms, Experimental

A prospective study compared five different assays for serum prostatic acid phosphatase in the detection of carcinoma of the prostate gland. The assays included two radioimmunoassay procedures, one counterimmunoelectrophoresis procedure, and an enzymatic procedure using alpha-naphthol phosphate substrate with and without sodium tartrate inhibition. The patients' hospital records were reviewed, as were all available surgical histology slides. The patients were divided into four groups: prostatic carcinoma, benign prostatic hypertrophy, other carcinomas (besides prostatic carcinoma), and no related disease states (that would be expected to give elevated acid phosphatase levels). The results were analyzed with respect to sensitivity, specificity, predictive value of a positive result, predictive value of a negative result, and efficiency of the assays.

Topics: Acid Phosphatase; Adenocarcinoma; Carcinoma; Colonic Neoplasms; Counterimmunoelectrophoresis; Enzyme-Linked Immunosorbent Assay; Humans; Lung Neoplasms; Male; Prospective Studies; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Stomach Neoplasms

The activities of alpha-naphthyl butyrate esterase, non-specific esterase, indoxyl esterase and acid phosphatase were studied histochemically in macrophages in cultures and in tissue sections of primary tumours and metastases of Lewis lung carcinoma (3LL). All macrophages in culture were stained by the alpha-naphthyl butyrate esterase procedure. In tissue sections, macrophages were intensely stained by the butyrate esterase procedure, while the tumour cells were not stained at all; macrophages were easily differentiated from 3LL cells. Non-specific esterase was evident in both tumour cells and macrophages. Indoxyl esterase and acid phosphatase were present in macrophages at the margin of the tumour only. The alpha-naphthyl butyrate esterase-positive macrophages differed in shape and location from acid phosphatase and indoxyl esterase-positive macrophages. This may indicate a difference in characteristics between macrophages found inside a tumour and those found at the tumour margins.

Topics: Acid Phosphatase; Animals; Carboxylic Ester Hydrolases; Esterases; Histocytochemistry; Indicators and Reagents; Lung Neoplasms; Macrophages; Mice; Staining and Labeling

Topics: Acid Phosphatase; Adenosine Triphosphatases; Adjuvants, Immunologic; Animals; Carcinoma; Endotoxins; Immunosuppressive Agents; Lung Neoplasms; Lymphocytes; Male; Mycobacterium bovis; Neoplasm Proteins; Neoplasms, Experimental; Oligomycins; Propionibacterium acnes; Rats; Sarcoma, Yoshida; Spleen

In six patients with known prostatic adenocarcinoma, extraprostatic (metastatic) tumor was suspected on radiographic or radionucleotide studies. When cytological examination of tissue obtained by needle aspiration or biopsy was nondiagnostic, radial gel immunodiffusion was used to identify the presence of prostatic acid phosphatase in the tissue. Four specimens demonstrated prostate-specific acid phosphatase activity, permitting the diagnosis of metastatic prostatic adenocarcinoma. The technique is simple and highly specific.

Topics: Acid Phosphatase; Adenocarcinoma; Aged; Bone Neoplasms; Humans; Immunodiffusion; Lung Neoplasms; Male; Neoplasm Metastasis; Prostatic Neoplasms

A series of 25 cases of lung cancer are presented in which total (TAcP) and nonprostatic serum acid phosphatase (NPAcP) activities were measured. Of these cases, 36% had raised TAcP and NPAcP activities in their serum. However, the serum activities of TAcP and NPAcP did not correlate with either the presence of lung cancer nor with the morphological tumour type. This fact indicates that, despite isolated reports of raised serum acid phosphatase activities in cases of lung cancer, acid phosphatase is of no value as a marker for lung cancer. We sought alternative explanations for the raised TAcP and NPAcP activities observed in our series in the hope that this enzyme might prove useful as a marker for early metastatic disease in lung cancer patients. This possibility is not substantiated, and the findings are analyzed and discussed. It is tentatively suggested that raised NPAcP activities in patients with lung cancer may relate to haemostasis.

Topics: Acid Phosphatase; Adult; Aged; Calcium; Female; Humans; Immunoenzyme Techniques; Liver Function Tests; Lung Neoplasms; Male; Middle Aged; Phosphates; Platelet Count

A murine melanoma variant (B16-F10ir6), resistant to lymphocytic cytolysis, has been shown previously to produce lower numbers of tumor nodules in the lung of C57BL/6J mice following i.v. inoculations. These differences found in tumor implantation and lymphocyte recognition may be due to changes in surface properties of this cell line. Therefore, membrane-bound sialic acid (released by Vibrio cholerae neuraminidase treatment), ectosialyltransferase activity, and total cellular glycosidase levels were measured in this cell line and compared with levels in its parent melanoma tumor cell line, B16-F10, which was selected for its enhanced ability to form tumor nodules. The results of these studies indicate a correlation between the degree of lung implantation and the amount of tumor cell sialic acid accessible to neuraminidase cleavage, tumor cell surface sialyltransferase activity, and several cellular glycosidase activities. These results are consistent with the idea that membrane structural changes in the glycocalyx may account for the ability of a tumor cell to implant and metastasize.

Topics: Acid Phosphatase; Animals; Cell Line; Cell Membrane; Glycoside Hydrolases; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Sialic Acids; Sialyltransferases; Transferases

An immunohistochemical method for detecting prostatic acid phosphatase is described for the diagnosis of metastatic prostatic carcinoma. The specific antiserum against prostatic acid phosphatase was prepared from rabbit by injection of acid phosphatase purified from seminal fluid. This method gives a selective staining of the cytoplasm of the glandular epithelial cells of prostatic tissue specimens on paraffin section. Most of the non-prostatic tissues were negative except for occasional weak staining in granulocytes, islet cells of pancreas, parietal cells of stomach, tubular epithelial cells of kidney, and liver cells. Also examined were 50 consecutive cases of metastatic tumor involving the bone marrow and 5 cases of metastatic prostatic carcinoma involving the lymph node or lung. All 20 cases with prostatic primary lesion showed positive staining. All other cases were negative, except 5 of the 14 cases of metastatic breast carcinoma in women showing weakly positive results. The method is fairly specific for identification of metastatic prostatic carcinoma. Occasional positive staining in breast tumor needs further study to establish whether the staining is due to the same isoenzyme or to certain cross immunoreactivity.

Topics: Acid Phosphatase; Aged; Clinical Enzyme Tests; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Prostatic Neoplasms; Staining and Labeling

A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase (PAP) measurement has been developed as modified from our previously reported immunofluoroassay, utilizing the specific anti-PAP antibodies conjugated to CNBr-activated Sepharose 4B. The serum prostatic acid phosphatase was bound, and separated from other acid phosphatases and serum proteins, by the solid-phase anti-PAP IgG Sepharose 4B. The enzyme activity was quantitated by measuring the enzyme hydrolytic product, alpha-naphthol, from a primary standard solution. The entire procedure could be performed within four hours. The sensitivity of this method was 0.22 I.U./l of enzyme activity or 0.88 ng of prostatic acic phosphatase protein per ml of serum. Normal range of serum prostatic acid phosphatase as determined by this assay was found to be 0.4--2.4 I.U./l of enzyme activity (or 1.60--9.60 ng of enzyme protein per ml of serum). Initial clinical evaluation showed that 19 of 25 patients with early stages of prostatic cancer and 12 of 14 patients with metastatic prostatic cancer exhibited an elevated enzyme level (overall 79%), as compared with only six and eight patients, respectively (overall 36%), by a conventional chemical method.

Topics: Acid Phosphatase; Adult; Aged; Breast Neoplasms; Female; Humans; Immunoassay; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prostate; Prostatic Neoplasms; Reference Values

Lysosomal enzymes were elevated about two-fold in primary s.c. Lewis lung carcinoma as compared with metastatic nodules in the lung. In a time course experiment, a general two-fold elevation of acid phosphatase and several glycosidases was observed in the primary tumor between the 14th and 17th postimplant day following s.c. inoculation of Lewis lung carcinoma. This increase in hydrolytic enzyme activity was not due to necrosis in the primary tumor since a comparison of enzyme activities in the nonnecrotic and necrotic areas demonstrated much higher activities in the nonnecrotic areas. No increases in lysosomal enzyme activity were observed with time in Sarcoma 180, a tumor which does not metastasize. There was no change with time in primary Lewis lung tumor lactate dehydrogenase activity while a 7-fold increase in serum lactate dehydrogenase activity was observed in tumor-bearing mice. Mitochondrial succinate-2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium reductase levels fell in the primary Lewis lung tumor as the tumor size increased. A positive correlation was observed between the time of the elevations of tumor lysosomal enzymes in Lewis lung carcinoma and the appearance of micro- and macrometastatic lesions in the lungs. The mechanisms accounting for the increased intratumoral lysosomal enzymes are unknown, but they may be related to macrophage infiltration or other tumor-host interactions which may facilitate the dissemination of tumor cells.

Topics: Acid Phosphatase; Animals; Carcinoma; Female; Glycoside Hydrolases; L-Lactate Dehydrogenase; Lung Neoplasms; Lysosomes; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Oxidoreductases; Sarcoma, Experimental; Time Factors

Immunopotentiated rats, which were injected with Propionibacterium acnes or BCG, had the 50% survival twice as long as those in untreated controls after intravenous inoculation of Sato lung carcinoma (SLC) cells. The amount of labeled tumor cells in the lung of the adjuvant-treated rats decreased significantly in the first 20 hr after intravenous injection of 51Cr-labeled tumor cells compared to that of control animals. The elevated activities of ATPase and acid phosphatase in the whole nucleated spleen cells as well as spleen lymphocytes separated by Ficoll-Conray gradient were also demonstrated in adjuvant-treated groups. These data suggested that the elevation of ATPase and acid phosphatase activities in nucleated spleen cells as well as spleen lymphocytes has an important role for the suppression of tumor growth in adjuvant-treated rats.

Topics: Acid Phosphatase; Adenosine Triphosphatases; Animals; BCG Vaccine; Carcinoma; Lung Neoplasms; Lymphocytes; Male; Mycobacterium bovis; Neoplasms, Experimental; Propionibacterium acnes; Rats; Spleen

The histological, histochemical and cytological changes were reported in 6 patients with primary lymphosarcoma of the lung. All cases are diffuse lymphocytic lymphosarcomas, histochemically with a similar enzymatic behaviour. Cytologically, small lymphocytes with different degrees of anaplasia were observed.

Topics: Acid Phosphatase; Alkaline Phosphatase; Cytochrome Reductases; Female; Glucosephosphate Dehydrogenase; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphoric Monoester Hydrolases

Cytologic assay of metastatic involvement of lymph nodes may be used along with histological studies as a reliable adjunct for morphological diagnosis, that makes possible in many cases to determine not only the epithelial origin of the affection but also to characterize its histological pattern. However, the cytologic diagnosis of undifferentiated cancer metastases is frequently rather difficult in relation to establishing the differential diagnosis between the former and other affections of lymph nodes. A careful, and sometimes repeated analysis of the material, taking into account the clinical data and cytochemical findings, contributes to greater efficiency of a cytologic method. The perspective use of cytochemical reactions as additional criteria for the diagnosis of undifferentiated cancer necessitates their further elaboration and study.

Topics: Acid Phosphatase; Enzyme Activation; Esterases; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Nasopharyngeal Neoplasms

Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Cricetinae; Histocytochemistry; L-Lactate Dehydrogenase; Lung; Lung Neoplasms; Malate Dehydrogenase; Male; Neoplasms, Radiation-Induced; Polonium; Succinate Dehydrogenase

Topics: Acid Phosphatase; Asthma; Histocytochemistry; Humans; Lung Diseases; Lung Neoplasms; Neutrophils; Sarcoidosis

Lactic dehydrogenase (LDH), glutamic-oxalacetic transaminase (GOT), and acid and alkaline phosphatase activities in bone marrow and in cubital vein serum were compared. For patients without cancer, marrow serum LDH attained levels four times as high, and GOT and alkaline phosphatase, levels twice as high as those normal for cubital vein serum; levels of acid phosphatase were the same for both sources. For patients with cancer, significant increase of enzyme levels over reference levels depends on the tumor origin and on the presence and localization of metastases. Marrow enzyme levels may become elevated with or without concurrent elevation in cubital vein serum. Concurrent elevations were found with colonic carcinoma and lymphoid leukemia, and noncurrent elevations, with prostatic cancer, myeloid leukemia, and myeloma. A nonconcurrent elevation of marrow enzymes indicates that the origin of the enzyme is in the marrow, whereas with concurrent elevation, the source of the enzyme may be another organ.

Topics: Acid Phosphatase; Alkaline Phosphatase; Aspartate Aminotransferases; Bone Marrow; Colonic Neoplasms; Humans; L-Lactate Dehydrogenase; Leukemia; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms

The mechanism of stroma-formation and rearrangement of the stroma was studied on 221 cases of cancer of the lung, stomach and mammary gland using histological, histochemical and electron-microscopy methods of investigation. It was established that multiplying epithelial elements of teh tumour induced proliferation of histiogenic and vascular fibroblasts, activating them. Active fibroblasts play a double role: they either produce fibres and interstitial matter of the tumorous stroma, or participate in desintegration of preceding and newly formed collagenous structures. The processes of stroma-formation comply with the conventional schemes of normal fibrillogenesis and rearrangement of the interstitial tissue. It was shown that fibroblasts of the tumour stroma was capable of phagocytosis of a mature collagen. It is supposed that in the course of the tumorous growth correlation between the parenchyma and stroma is maintained, the leading role being played by the epithelium.

Topics: Acid Phosphatase; Breast Neoplasms; Collagen; Fibroblasts; Glycosaminoglycans; Histocytochemistry; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Microscopy, Electron; Stomach Neoplasms; Tropocollagen

Topics: Acid Phosphatase; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adenosine Triphosphatases; Adult; Aged; Alkaline Phosphatase; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Oxidoreductases

A radiologic method of measuring metastases was developed and statistically analyzed with respect to survival based on 103 patients with known metastases at diagnosis. The analysis revealed a significant correlation between shortened patient survival and the combination of number of sites involved and the extent of involvement within each site. These quantitative analysis are useful in predicting patient survival and in studying response to treatment.

Topics: Acid Phosphatase; Bone Neoplasms; Humans; Lumbar Vertebrae; Lung Neoplasms; Male; Models, Biological; Neoplasm Metastasis; Pelvis; Prognosis; Prostatic Neoplasms; Radiography, Thoracic; Risk; Thoracic Vertebrae

The measurement of acid and alkaline phosphatase and cathepsin activities in bronchial aspirates obtained through bronchoscopy from a series of 75 patients suggests a procedure that may have value as a routine diagnostic examination. Using this approach, seven patients with neoplasms in the lung showed elevated levels of alkaline phosphatase and cathepsin in bronchial aspirates without elevation in acid phosphatase activity.

Topics: Acid Phosphatase; Alkaline Phosphatase; Bronchi; Bronchial Neoplasms; Bronchitis; Bronchoscopy; Cathepsins; Humans; Isoenzymes; Lung Neoplasms

Topics: Acid Phosphatase; Adenocarcinoma; Adenosine Triphosphatases; Alkaline Phosphatase; Bronchi; Bronchial Neoplasms; Carcinoma, Squamous Cell; Esterases; Giant Cell Tumors; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Glycerolphosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Lung; Lung Neoplasms; Malate Dehydrogenase; NADH, NADPH Oxidoreductases; Neoplasm Metastasis; Oxidoreductases; Phosphogluconate Dehydrogenase; Phosphoric Monoester Hydrolases; Succinate Dehydrogenase

Topics: Acid Phosphatase; Adenocarcinoma; Alkaline Phosphatase; Aminopeptidases; Carcinoma; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Esterases; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Glycerolphosphate Dehydrogenase; Histocytochemistry; Humans; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Lung Neoplasms; Malate Dehydrogenase; NADH, NADPH Oxidoreductases; Nucleotidases; Phosphogluconate Dehydrogenase; Succinate Dehydrogenase

Topics: Acid Phosphatase; Adolescent; Adult; Age Factors; Animals; Animals, Newborn; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Cell Line; Child; Child, Preschool; Female; Fluorescent Antibody Technique; Hodgkin Disease; Humans; Infant; Leukemia; Lung Neoplasms; Lysosomes; Male; Melanoma; Microscopy, Electron; Middle Aged; Osteosarcoma; Rats; Sarcoma; Sex Factors; Statistics as Topic

Topics: Acid Phosphatase; Adrenalectomy; Alkaline Phosphatase; Bone Neoplasms; Castration; Diethylstilbestrol; Humans; Hypophysectomy; Lung Neoplasms; Male; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms; Radiography; Retrospective Studies

Topics: Acid Phosphatase; Bone Neoplasms; Electrophoresis, Polyacrylamide Gel; Humans; Isoenzymes; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms

Topics: Acid Phosphatase; Adenoma; Adenosine Triphosphatases; Alkaline Phosphatase; Aminopeptidases; Bronchial Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Bronchogenic; Clinical Enzyme Tests; Diagnosis, Differential; Dihydrolipoamide Dehydrogenase; Esterases; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Glycerolphosphate Dehydrogenase; Hamartoma; Histocytochemistry; Humans; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Leiomyoma; Lung Neoplasms; Malate Dehydrogenase; Nucleotidases; Phosphogluconate Dehydrogenase; Succinate Dehydrogenase

Topics: Acid Phosphatase; Alkaline Phosphatase; Breast Neoplasms; Clinical Enzyme Tests; Diagnosis, Differential; Esophageal Neoplasms; Hodgkin Disease; Humans; Leukocytes; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Rectal Neoplasms; Stomach Neoplasms

Topics: Acid Phosphatase; Adult; Aged; Alkaline Phosphatase; Androgen Antagonists; Bone Neoplasms; Carcinoma; Cyproterone; Estrogens; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pregnadienes; Prostatic Neoplasms

Topics: Acid Phosphatase; Autopsy; Carcinoma; Chromaffin System; Diagnosis, Differential; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Prostatic Neoplasms; Spinal Neoplasms; Urinary Bladder Neoplasms

Topics: Acid Phosphatase; Adult; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Humans; Iron Isotopes; Lung Neoplasms; Male; Mandibular Neoplasms; Mouth Neoplasms; Neoplasm Metastasis; Osteosarcoma; Pelvic Neoplasms; Pharyngeal Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Spinal Neoplasms; Strontium Isotopes

Topics: Acid Phosphatase; Animals; Antidepressive Agents; Diagnosis, Differential; Glucuronidase; Indoles; Iprindole; Lung Neoplasms; Lymphatic Diseases; Macrophages; Male; Microscopy, Electron; Phagocytosis; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Thorium Dioxide

Topics: Acid Phosphatase; Adult; Albumins; Bile Acids and Salts; Carcinoma, Hepatocellular; Esterases; Fibrinogen; Glycogen; Histocytochemistry; Humans; Hydroxyindoleacetic Acid; Lipids; Lipoproteins; Liver Neoplasms; Lung Neoplasms; Male; Malignant Carcinoid Syndrome; Microscopy, Electron; Peroxidases; Serotonin; Staining and Labeling; Transferrin

Topics: Acid Phosphatase; Alkaline Phosphatase; Bilirubin; Colonic Neoplasms; Esophageal Neoplasms; Humans; Kidney Neoplasms; Leukemia, Myeloid; Liver Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms; Pancreatic Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Prostatic Neoplasms; Rectal Neoplasms; Sphingolipids; Stomach Neoplasms; Thyroid Neoplasms; Triglycerides; Urinary Bladder Neoplasms

Topics: 17-Ketosteroids; Acid Phosphatase; Adenocarcinoma; Adrenocorticotropic Hormone; Cushing Syndrome; Cytoplasmic Granules; Glucocorticoids; Histocytochemistry; Hormones, Ectopic; Humans; Hydrocortisone; Lung Neoplasms; Male; Metyrapone; Middle Aged; Oxidoreductases; Pituitary-Adrenal Function Tests; Pyrophosphatases

Topics: Acid Phosphatase; Acute Disease; Age Factors; Alkaline Phosphatase; Animals; Avitaminosis; Bone Neoplasms; Carcinoma; Chronic Disease; Diabetes Mellitus; Esophageal Neoplasms; Estrus; Female; Hematologic Diseases; Hemoglobinuria, Paroxysmal; Histocytochemistry; Hodgkin Disease; Humans; Infections; Leukemia; Leukocytes; Liver Diseases; Lung Neoplasms; Male; Myocardial Infarction; Neutrophils; Pregnancy; Prostatic Neoplasms; Radiation Injuries; Stress, Physiological

Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Glucuronidase; Golgi Apparatus; Histocytochemistry; Lung Neoplasms; Male; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Oxidoreductases; Rats; Succinate Dehydrogenase

Topics: Acid Phosphatase; Alkaline Phosphatase; Carcinoma, Squamous Cell; Choriocarcinoma; Duodenal Neoplasms; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Pregnancy; Stomach Neoplasms; Tongue Neoplasms

Topics: Acid Phosphatase; Adenocarcinoma; Carcinoma; Colonic Neoplasms; Coloring Agents; Diagnosis, Differential; Histocytochemistry; Histological Techniques; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Pathology; Prostatic Neoplasms; Rhabdomyosarcoma; Sarcoma; Staining and Labeling; Urinary Bladder Neoplasms

Topics: Acid Phosphatase; Alkaline Phosphatase; Communicable Diseases; Diabetes Mellitus; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Heart Diseases; Hematologic Diseases; Humans; Kidney Diseases; Leukocytes; Liver Diseases; Lung Neoplasms; Mental Disorders; Neurologic Manifestations; Thyroid Diseases

Topics: Acid Phosphatase; Alkaline Phosphatase; Bronchiectasis; Diagnosis, Differential; Humans; Lung Abscess; Lung Neoplasms; Neoplasms; Serum; Tuberculosis; Tuberculosis, Pulmonary

Topics: Acid Phosphatase; Adenocarcinoma; Alkaline Phosphatase; Castration; Drug Therapy; Estrogens; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms; Orchiectomy; Pathology; Radiography, Thoracic; Seminal Vesicles; Testis; Urography

Topics: Acid Phosphatase; Alanine Transaminase; Alkaline Phosphatase; Amylases; Aspartate Aminotransferases; Breast Neoplasms; Clinical Enzyme Tests; Colonic Neoplasms; D-Alanine Transaminase; Humans; L-Lactate Dehydrogenase; Lipase; Lung Neoplasms; Male; Pancreatic Neoplasms; Stomach Neoplasms; Testicular Neoplasms

Topics: Acid Phosphatase; Bronchi; Humans; Lipase; Lung Neoplasms; Neoplasms; Phosphoric Monoester Hydrolases